These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32737615)

  • 21. Practical Approach to Modeling the Impact of Amorphous Drug Nanoparticles on the Oral Absorption of Poorly Soluble Drugs.
    Stewart AM; Grass ME
    Mol Pharm; 2020 Jan; 17(1):180-189. PubMed ID: 31743032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of osmolality on gastrointestinal fluid volume and drug absorption: potential impact on oral salt supplementation.
    Takemura M; Tanaka Y; Inoue K; Tamai I; Shirasaka Y
    J Pharm Health Care Sci; 2021 Sep; 7(1):29. PubMed ID: 34465382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Physiologically Based Pharmacokinetic (PBPK) Modeling to Evaluate the Impact of Pharmaceutical Excipients on Oral Drug Absorption: Sensitivity Analyses.
    Chow EC; Talattof A; Tsakalozou E; Fan J; Zhao L; Zhang X
    AAPS J; 2016 Nov; 18(6):1500-1511. PubMed ID: 27520379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant intake of alcohol may increase the absorption of poorly soluble drugs.
    Fagerberg JH; Sjögren E; Bergström CAS
    Eur J Pharm Sci; 2015 Jan; 67():12-20. PubMed ID: 25444841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability.
    Lin HS; Ho PC
    J Pharm Sci; 2011 Oct; 100(10):4491-500. PubMed ID: 21520090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances and challenges in PBPK modeling--Analysis of factors contributing to the oral absorption of atazanavir, a poorly soluble weak base.
    Berlin M; Ruff A; Kesisoglou F; Xu W; Wang MH; Dressman JB
    Eur J Pharm Biopharm; 2015 Jun; 93():267-80. PubMed ID: 25872159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of nobiletin-methyl hesperidin amorphous solid dispersion: Novel application of methyl hesperidin as an excipient for hot-melt extrusion.
    Iwashita M; Hashizume K; Umehara M; Ishigami T; Onishi S; Yamamoto M; Higashi K; Moribe K
    Int J Pharm; 2019 Mar; 558():215-224. PubMed ID: 30654059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward simplified oral lipid-based drug delivery using mono-/di-glycerides as single component excipients.
    Ilie AR; Griffin BT; Vertzoni M; Kuentz M; Cuyckens F; Wuyts K; Kolakovic R; Holm R
    Drug Dev Ind Pharm; 2020 Dec; 46(12):2051-2060. PubMed ID: 33124918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new lipid excipient, phosphorylated tocopherol mixture, TPM enhances the solubilisation and oral bioavailability of poorly water soluble CoQ
    Pham AC; Gavin P; Libinaki R; Ramirez G; Boyd BJ
    J Control Release; 2017 Dec; 268():400-406. PubMed ID: 29097302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel intravenous vehicle for preclinical cardiovascular screening of small molecule drug candidates in rat.
    Banfor PN; Gintant GA; Lipari JM; Zocharski PD
    J Pharmacol Toxicol Methods; 2016; 82():62-67. PubMed ID: 27432021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Delivery of Highly Lipophilic, Poorly Water-Soluble Drugs: Self-Emulsifying Drug Delivery Systems to Improve Oral Absorption and Enable High-Dose Toxicology Studies of a Cholesteryl Ester Transfer Protein Inhibitor in Preclinical Species.
    Chen XQ; Ziemba T; Huang C; Chang M; Xu C; Qiao JX; Wang TC; Finlay HJ; Salvati ME; Adam LP; Gudmundsson O; Hageman MJ
    J Pharm Sci; 2018 May; 107(5):1352-1360. PubMed ID: 29317226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Evaluation of Dissolution and Permeation of Oral Drug Solid Formulations for Predicting Absorption Rate-Limiting Factors and In Vitro-In Vivo Correlations: Case Study Using a Poorly Soluble Weakly Basic Drug.
    Li Z; He X; Tian S; Feng G; Huang C; Xun M; Wu Z; Wang Y
    AAPS PharmSciTech; 2019 Oct; 20(8):321. PubMed ID: 31650430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs.
    Kataoka M; Masaoka Y; Yamazaki Y; Sakane T; Sezaki H; Yamashita S
    Pharm Res; 2003 Oct; 20(10):1674-80. PubMed ID: 14620525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption.
    Kaur N; Narang A; Bansal AK
    Eur J Pharm Biopharm; 2018 Aug; 129():222-246. PubMed ID: 29879527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs.
    Schwebel HJ; van Hoogevest P; Leigh ML; Kuentz M
    Pharm Dev Technol; 2011 Jun; 16(3):278-86. PubMed ID: 20214530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.
    Arndt M; Chokshi H; Tang K; Parrott NJ; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2013 Aug; 84(3):633-41. PubMed ID: 23434923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis.
    Avdeef A; Kansy M; Bendels S; Tsinman K
    Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.